A Canine Urinary Tract Infection Representing the First Clinical Veterinary Isolation of Acinetobacter ursingii by Salavati, Silke et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A Canine Urinary Tract Infection Representing the First Clinical
Veterinary Isolation of Acinetobacter ursingii
Citation for published version:
Salavati, S, Taylor, C, Harris, J & Paterson, G 2018, 'A Canine Urinary Tract Infection Representing the
First Clinical Veterinary Isolation of Acinetobacter ursingii' New Microbes and New Infections, vol 22, pp. 4-
5. DOI: 10.1016/j.nmni.2017.11.007
Digital Object Identifier (DOI):
10.1016/j.nmni.2017.11.007
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
New Microbes and New Infections
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 13. Apr. 2018
Accepted Manuscript
A Canine Urinary Tract Infection Representing the First Clinical Veterinary Isolation of
Acinetobacter ursingii
Silke Salavati, Claire S. Taylor, Jennifer D. Harris, Gavin K. Paterson
PII: S2052-2975(17)30096-3
DOI: 10.1016/j.nmni.2017.11.007
Reference: NMNI 384
To appear in: New Microbes and New Infections
Received Date: 22 August 2017
Revised Date: 23 November 2017
Accepted Date: 24 November 2017
Please cite this article as: Salavati S, Taylor CS, Harris JD, Paterson GK, A Canine Urinary Tract
Infection Representing the First Clinical Veterinary Isolation of Acinetobacter ursingii, New Microbes and
New Infections (2018), doi: 10.1016/j.nmni.2017.11.007.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
A Canine Urinary Tract Infection Representing the First Clinical Veterinary Isolation of 
Acinetobacter ursingii  
Silke Salavati1,3, Claire S. Taylor2, Jennifer D. Harris2, Gavin K. Paterson2,3* 
1Hospital for Small Animals, Royal (Dick) School of Veterinary Studies, University of 
Edinburgh, UK. 
2Easter Bush Pathology, Royal (Dick) School of Veterinary Studies, University of Edinburgh, 
UK. 
3The Roslin Institute, University of Edinburgh, UK. 
*gavin.paterson@ed.ac.uk 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
1 
 
Manuscript category: First Clinical Case Report 1 
 2 
A Canine Urinary Tract Infection Representing the First Clinical Veterinary Isolation of 3 
Acinetobacter ursingii  4 
 5 
Abstract  6 
Acinetobacter species can be important opportunistic pathogens in humans, especially in 7 
health care settings. We report here the first isolation of Acinetobacter ursingii from an 8 
animal species where it was isolated from a canine urinary tract infection and where 9 
phenotypic identification proved unreliable.  10 
 11 
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Acinetobacter species cause a wide range of infections in humans with those most 26 
frequently isolated belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii 27 
complex (1). While other species are pathogenic, much less is known about their 28 
epidemiology and their laboratory identification can be unreliable (2, 3). A Gram-negative 29 
bacilli, isolate 76496, was cultured from free catch urine received from an 8.5 year old, male 30 
Border Terrier submitted for diagnosis to Easter Bush Pathology, University of Edinburgh. 31 
The dog had a previous history of acute kidney injury of unknown origin, resulting in 32 
permanent reduction of renal function (chronic kidney disease) and was presented for a 33 
routine re-check. The urine culture was pure with a viable count of >106 cfu/ml. While this 34 
does not confirm the isolate as the definite cause of chronic kidney disease and a free catch 35 
can be susceptible to contamination, the heavy growth and purity indicates clinical 36 
significance. Phenotypic identification using Vitek2 and Analytical Profile Index (API) failed to 37 
give a reliable identification. In the case of Vitek2, a ‘Low Discrimination’ result with the 38 
Bionumber: 0040001101501000 was returned using the Gram-negative (GN) identification 39 
card. Three possible organisms were listed: Pseudomonas fluorescens, Acinetobacter lwoffii 40 
and Bordetella bronchiseptica. A repeat analysis gave the result as ‘unidentified’ with the 41 
similar Bionumber: 0040000101501000.  The API 20 NE strip (for non-fastidious, non-enteric 42 
Gram-negative rods) gave an ‘Acceptable identification to the genus’ for Acinetobacter with 43 
the numerical code 0000071 and Acinetobacter junii/johnsonii (63.1%) and Acinetobacter 44 
baumannii/calcoaceticus (26.1%) given as the significant taxa. 16S rDNA sequencing was 45 
therefore used to identify the isolate. A 16S rDNA was amplified by PCR with primers fD1 46 
and rP2 (4) and sequenced on both strands with primers fD1 and rP2, and 519r, 536f, 357f  47 
and 1385r (5). Using EzBioCloud (6) this 1402 bp partial 16S sequence yielded a 100% 48 
match to that of the Acinetobacter ursingii type strain DSM 16037 (Accession AIEA01000080 49 
at positions 29-1430). Susceptibility testing by disc diffusion found the isolate susceptible to 50 
all antimicrobials tested: ampicillin, amoxicillin/clavulanate, cephalexin, clindamycin, 51 
enrofloxacin, erythromycin, and trimethoprim/sulphonamide. This antibiogram may indicate a 52 
possible community/environmental source rather than being nosocomially acquired. 53 
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The dog received a 1 week course of amoxicillin/clavulanate, resulting in a negative culture 54 
from a follow-up urine sample 10 days after cessation of treatment. 55 
First identified in 2001, A. ursingii has been isolated from various human infections including 56 
urinary tract infection (2, 7, 8). Dortet et al. (2) describe similar problems with the phenotypic 57 
identification of A. ursingii to those encountered here, and suggest therefore that the true 58 
prevalence of A. ursingii infection may be underestimated. Notably, 9/10 of their studied A. 59 
ursingii isolates gave the API 20 NE numerical code of 0000071, identical to our isolate, 60 
leading them to propose that such a result represents a ‘reasonably reliable’ approach to 61 
identify A. ursingii (2). The poor reliably of Vitek2 for the identification of A. ursingii has also 62 
been reported in a further study (3). 63 
This report is the first veterinary isolation of A. ursingii and this organism must be considered 64 
as a possible aetiological agent in veterinary diagnostic laboratories. This is especially the 65 
case where phenotypic tests are inconclusive but indicative of an Acinetobacter species with 66 
identification by molecular approaches advisable. Given the potential for Acinetobacter 67 
species to carry multi-drug resistance, although that was not the case here, and to cause 68 
nosocomial infections it is important for veterinary microbiology to accurately identify these 69 
and track their epidemiology.   70 
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